» Authors » Wasim Dar

Wasim Dar

Explore the profile of Wasim Dar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ebadinejad A, Cobar J, Cyr-Long P, Dar W, Emmanuel B, Morgan G, et al.
J Am Coll Surg . 2025 Feb; PMID: 39918209
Background: In July 2022, the Organ Procurement Transplant Network (OPTN) mandated race-neutral eGFR calculations when evaluating kidney transplant (KT) candidates, replacing historic race-based estimates. This modification also required transplant programs...
2.
Ebadinejad A, Silver E, OSullivan D, Dar W, Morgan G, Emmanuel B, et al.
Nephrology (Carlton) . 2025 Jan; 30(1):e14431. PMID: 39821923
Aim: Henoch-Schönlein purpura (HSP) nephritis leads to end-stage renal disease (ESRD) in upto 3% of cases, necessitating kidney transplantation (KT). This study compared graft and patient survival outcomes between HSP...
3.
Becker E, Siddique O, OSullivan D, Dar W, Einstein M, Morgan G, et al.
Transplantation . 2024 Feb; 108(8):e181-e186. PMID: 38419160
Background: Nonalcoholic steatohepatitis (NASH) is the fastest-growing indication for liver transplantation (LT). Sex disparities among patients with cirrhosis on the LT waitlist are well known. We wanted to understand these...
4.
Wade J, Petitpas K, Dar W, Ali A, Radojevic J, Lawlor M, et al.
Transplant Proc . 2023 Jul; 55(8):1793-1798. PMID: 37487863
Background: There is a paucity of evidence on the risk of donor-recipient transmission of the SARS-CoV-2 in solid organ transplant recipients. Initial impressions suggest non-lung solid organs may be safely...
5.
Althoff A, Ali M, OSullivan D, Dar W, Emmanuel B, Morgan G, et al.
Transplant Proc . 2022 Oct; 54(8):2263-2269. PMID: 36243574
Background: Racial and ethnic minorities are disproportionally affected by end-stage liver disease. Unfortunately, disparities in referrals to liver transplantation (LT), organ allocation, and posttransplant outcomes exist in this population. Methods:...
6.
Chen L, Wu N, Kennedy L, Francis H, Ceci L, Zhou T, et al.
Hepatology . 2021 Apr; 74(4):1845-1863. PMID: 33928675
Background And Aims: Human NAFLD is characterized at early stages by hepatic steatosis, which may progress to NASH when the liver displays microvesicular steatosis, lobular inflammation, and pericellular fibrosis. The...
7.
Wang Y, Yang Y, Wang M, Wang S, Jeong J, Xu L, et al.
Sci Transl Med . 2021 Feb; 13(579). PMID: 33536281
Eosinophils are a myeloid cell subpopulation that mediates type 2 T helper cell immune responses. Unexpectedly, we identified a rapid accumulation of eosinophils in 22 human liver grafts after hepatic...
8.
Kennedy L, Meadows V, Sybenga A, Demieville J, Chen L, Hargrove L, et al.
Hepatology . 2021 Jan; 74(1):164-182. PMID: 33434322
Background And Aims: Nonalcoholic fatty liver disease (NAFLD) is simple steatosis but can develop into nonalcoholic steatohepatitis (NASH), characterized by liver inflammation, fibrosis, and microvesicular steatosis. Mast cells (MCs) infiltrate...
9.
Kennedy L, Hargrove L, Demieville J, Bailey J, Dar W, Polireddy K, et al.
Am J Pathol . 2017 Dec; 188(3):600-615. PMID: 29248461
Feeding a high-fat diet (HFD) coupled with sugar, mimicking a Western diet, causes fatty liver disease in mice. Histamine induces biliary proliferation and fibrosis and regulates leptin signaling. Wild-type (WT)...
10.
Kwun J, Bulut P, Kim E, Dar W, Oh B, Ruhil R, et al.
Semin Immunol . 2011 Dec; 24(2):96-108. PMID: 22137187
The role of antibodies in chronic injury to organ transplants has been suggested for many years, but recently emphasized by new data. We have observed that when immunosuppressive potency decreases...